Distribution and Antimicrobial Activity of Fosfomycin in the Interstitial Fluid of Human Soft Tissues

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.44.10.2728-2732.2000PMID 10991852PMCID PMC90143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid

  2004cited by this paper
• Klebsiella pneumoniae Necrotizing F asciitis Associated w ith D iabetes a nd L iver C irrhosis

  2000cited by this paper
• Soft Tissue Infections

  2000cited by this paper
• Penetration of Ciprofloxacin into the Interstitial Space of Inflamed Foot Lesions in Non-Insulin-Dependent Diabetes Mellitus Patients

  1999cited by this paper
• Penetration of Moxifloxacin into Peripheral Compartments in Humans

  1999cited by this paper
• Distribution and Antimicrobial Activity of Ciprofloxacin in Human Soft Tissues

  1999cited by this paper
• Soft Tissue Infections

  1998cited by this paper
• Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans.

  1998cited by this paper
• Fosfomycin Tromethamine A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Efficacy as a Single-Dose Oral Treatment for Acute Uncomplicated Lower Urinary Tract Infections

  1997cited by this paper
• Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey.

  1997cited by this paper
• Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations.

  1997cited by this paper
• Soft tissue infections and the diabetic foot.

  1996cited by this paper
• Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans

  1996influential reference
• Determination of fosfomycin in human urine by capillary gas chromatography: Application to clinical pharmacokinetic studies

  1996cited by this paper
• Necrotizing fasciitis.

  1996cited by this paper
• Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans.

  1993cited by this paper
• In vitro activity of fosfomycin against 'problem' gram-positive cocci.

  1992cited by this paper
• Microdialysis—principles and applications for studies in animals and man

  1991cited by this paper
• [Perioperative preventive antibiotic treatment with fosfomycin in heart surgery: serum kinetics in extracorporeal circulation and determination of concentration in heart valve tissue].

  1990cited by this paper
• Adjuvant fosfomycin medication in chronic osteomyelitis

  1989cited by this paper
• Linearity of the pharmacokinetics of phosphomycin in serum and interstitial tissue fluid in rabbits.

  1986cited by this paper
• Effect of protein binding on antibiotic activity in vivo.

  1983cited by this paper
• A problem in the interpretation of β-lactam antibiotic levels in tissues

  1983cited by this paper
• A problem in the interpretation of beta-lactam antibiotic levels in tissues.

  1983cited by this paper
• Surgical suppurating infections and surgical abdominal infections treated with fosfomycin.

  1977cited by this paper
• A study of the levels of fosfomycin in the cerebrospinal fluid in adult meningitis.

  1977cited by this paper
• Pharmacokinetics of fosfomycin.

  1977cited by this paper
• INFLUENCE OF BINDING ON THE PHARMACOLOGIC ACTIVITY OF ANTIBIOTICS

  1973cited by this paper

• Optimizing the Clinical Exposure of Fosfomycin in Critically Ill Adult Septic Patients: A Physiologically Based Pharmacokinetic Modeling.

  2025cites this paper
• Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults

  2024cites this paper
• Individualized antibiotic dosage regimens for patients with augmented renal clearance

  2023cites this paper
• Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers

  2023cites this paper
• In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates

  2023cites this paper
• High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients

  2022cites this paper
• Fosfomycin

  2022cites this paper
• Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review

  2022cites this paper
• Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I

  2022cites this paper
• Fosfomycin Pharmacokinetic Profile in Plasma and Urine and Quantitative Estimation in Prostate and Seminal Vesicles after One and Two Consecutive Doses of Oral Fosfomycin Trometamol in Healthy Male Volunteers

  2022cites this paper
• Fosfomycin and nitrofurantoin: classic antibiotics and perspectives

  2021cites this paper
• Dose Optimization of Combined Linezolid and Fosfomycin against Enterococcus by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model

  2021cites this paper
• Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time–Kill Approaches

  2021cites this paper
• Staphylococcus Aureus

  2020cites this paper
• The plasma pharmacokinetics of fosfomycin and metronidazole after intraperitoneal administration in patients undergoing appendectomy for uncomplicated appendicitis

  2020cites this paper
• In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa.

  2020cites this paper
• Fosfomycin: mechanisms and the increasing prevalence of resistance

  2019cites this paper
• Fosfomycin: the characteristics, activity, and use in critical care

  2019cites this paper
• The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.

  2019cites this paper
• In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

  2019cites this paper
• Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?

  2019cites this paper
• Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa

  2018cites this paper
• Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones

  2018cites this paper
• Fosfomicin u liječenju infekcija uzrokovanih višestruko otpornim bakterijama

  2018cites this paper
• Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli.

  2018cites this paper
• Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.

  2018cites this paper
• Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients

  2018cites this paper
• Pharmacodynamic evaluation of fosfomycin against E . coli and 1 Klebsiella spp . from urinary tract infections and the influence of pH 2 on fosfomycin activities 3 Running title : PK / PD of fosfomycin against urinary Enterobacteriaceae 4

  2017cites this paper
• Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers

  2017cites this paper
• Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae

  2017cites this paper
• 1 Pharmacodynamic evaluation of fosfomycin against E. coli and 1 Klebsiella spp. from urinary tract infections and the influence of pH 2 on fosfomycin activities 3

  2017cites this paper
• Fosfomycin: Pharmacological, Clinical and Future Perspectives

  2017cites this paper
• A rapid liquid chromatography-tandem mass spectrometry for the quantification of Fosfomycin in plasma, urine, and aqueous fluids.

  2017cites this paper
• Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities

  2017cites this paper
• Fosfomycin: Resurgence of an old companion.

  2016cites this paper
• Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.

  2016cites this paper
• Fosfomycin

  2016cites this paper
• Exploring the hidden potential of fosfomycin for the fight against severe Gram-negative infections

  2016cites this paper
• Frequency and Antimicrobial Susceptibility of Staphylococcus Aureus Isolated from Pus Samples of Paediatric Patients

  2016cites this paper
• Optimising use of fosfomycin against multidrug-resistant Pseudomonas aeruginosa

  2016cites this paper
• In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.

  2015cites this paper
• Population Pharmacokinetics of Fosfomycin in Critically Ill Patients

  2015cites this paper
• A simple LC-MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: application to a pilot pharmacokinetic study in humans.

  2015cites this paper
• Therapeutisches Drug Monitoring von Reserveantibiotika

  2015cites this paper
• Resistant Acinetobacter baumannii Infections : A Preliminary Study 2

  2014cites this paper
• Atomic force microscopy study of the antibacterial effect of fosfomycin on methicillin-resistant Staphylococcus pseudintermedius

  2014cites this paper
• Fosfomycin susceptibility of canine methicillin-resistant Staphylococcus pseudintermedius isolates.

  2014cites this paper
• In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius

  2014cites this paper
• Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.

  2014cites this paper
• A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring

  2014cites this paper
• Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

  2014cites this paper
• Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

  2014cites this paper
• A novel derivatization method for the determination of Fosfomycin in human plasma by liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometric detection via phase transfer catalyzed derivatization.

  2014cites this paper
• Methods to measure target site penetration of antibiotics in critically ill patients.

  2013cites this paper
• Microdialysis in Antibiotic Research

  2013cites this paper
• Assessment of Novel Antimicrobial Therapy against Methicillin-resistant Staphylococcus pseudintermedius Biofilm with Conventional Assays and a Microfluidic Platform

  2013influential citation
• What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.

  2013cites this paper
• Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents

  2013cites this paper
• Lemierre syndrome complicating multiple brain abscesses caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae cured by fosfomycin and meropenem combination therapy.

  2012cites this paper
• Applications of Pharmacokinetic/Pharmacodynamic Models for the Development of Antimicrobial Agents

  2012cites this paper
• Fosfomycin

  2012cites this paper
• The revival of fosfomycin.

  2011cites this paper
• Fosfomycin and Its Application in the Treatment of Multidrug-Resistant Enterobacteriaceae Infections

  2011cites this paper
• In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus

  2011cites this paper
• Microdialysis as a Monitoring System for Human Diabetes

  2011cites this paper
• A Reappraisal of Current Dosing Strategies for Intravenous Fosfomycin in Children and Neonates

  2011cites this paper
• In vitro susceptibility of canine and feline Escherichia coli to fosfomycin.

  2011cites this paper
• Increased Temperature Enhances the Antimicrobial Effects of Daptomycin, Vancomycin, Tigecycline, Fosfomycin, and Cefamandole on Staphylococcal Biofilms

  2010cites this paper
• Extracellular concentrations of fosfomycin in lung tissue of septic patients.

  2010cites this paper
• Fosfomycin: an old, new friend?

  2010cites this paper
• Pharmacokinetic/pharmacodynamic characterization of ceftobiprole

  2009cites this paper
• Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms

  2009cites this paper
• Multidrug-Resistant Gram-Negative Infections

  2009influential citation
• Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.

  2009cites this paper
• Effects of Azithromycin in Combination with Vancomycin, Daptomycin, Fosfomycin, Tigecycline, and Ceftriaxone on Staphylococcus epidermidis Biofilms

  2009cites this paper
• High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.

  2009cites this paper
• Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin

  2008cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.

  2008cites this paper
• Miscellaneous antibacterial drugs

  2007cites this paper
• Immunomodulatory Effects of Fosfomycin in Experimental Human Endotoxemia

  2007cites this paper
• Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.

  2006influential citation
• Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery

  2006cites this paper
• Immunomodulatory effects of fosfomycin in an endotoxin model in human blood.

  2006cites this paper
• Application of microdialysis for pharmacokinetic-pharmacodynamic modelling

  2006cites this paper
• Application of microdialysis in clinical pharmacology.

  2006cites this paper
• In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole

  2005cites this paper
• Antibiotic Abscess Penetration: Fosfomycin Levels Measured in Pus and Simulated Concentration-Time Profiles

  2005cites this paper
• Microdialysis

  2005cites this paper
• Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue

  2004cites this paper
• Linezolid Treatment of Skeletal Methicillin-Resistant Staphylococcus aureus Infection

  2004cites this paper
• Methods to assess tissue-specific distribution and metabolism of drugs.

  2004cites this paper
• Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.

  2004cites this paper
• Microdialysis

  2004cites this paper
• Penetration of Fosfomycin into Inflammatory Lesions in Patients with Cellulitis or Diabetic Foot Syndrome

  2003cites this paper
• Relevance of Soft-Tissue Penetration by Levofloxacin for Target Site Bacterial Killing in Patients with Sepsis

  2003influential citation
• Target site bacterial killing of cefpirome and fosfomycin in critically ill patients.

  2003cites this paper
• Target site penetration of fosfomycin in critically ill patients.

  2003cites this paper
• Muscle distribution of antimicrobial agents after a single intravenous administration to rats.

  2002cites this paper
• A review of membrane sampling from biological tissues with applications in pharmacokinetics, metabolism and pharmacodynamics.

  2002cites this paper